Skip to main content
. 2020 Aug;158(2):316–322. doi: 10.1016/j.ygyno.2020.05.002

Fig. 1.

Fig. 1

Survival curves of women with invasive epithelial tubo-ovarian cancer in the ‘no screening’ arm of UKCTOCS, with presenting symptoms included in (A) NICE guidelines vs not included (B) modified Goff symptom index vs not included.